Speaker illustration

Professor Ninian Nicholas Lang

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Society of Cardiology

Dr. Lang is a Reader (Associate Professor) in Cardiology at the Institute of Cardiovascular and Medical Sciences, University of Glasgow. He is an Honorary Consultant Cardiologist at the Queen Elizabeth University Hospital and the Beatson West of Scotland Cancer Centre. He runs the West of Scotland cardio-oncology service and integrates this clinical practice with an active research programme. His clinical trial and translational research in cardio-oncology and heart failure relate to vascular and myocardial injury induced by established and novel systemic anti-cancer therapies. He attended the University of Edinburgh Medical School, and later was awarded the Bristol-Myers Squibb Cardiovascular Prize Fellowship to undertake his PhD research. He is an Associate Editor of JACC:CardioOncology.

Cardiac dysfunction related to cancer therapy: diagnosis and prognostication.

Event: ESC Congress 2022

Topic: Pathophysiology and Mechanisms

Session: Prediction and management for cardiac dysfunction related to cancer therapy


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb